Email this article 
ROLE OF ENDOTHELIUM IN REMODELLING A MYOCARDIUM LEFT VENTRICULAR AT PATIENTS ON A HEMODIALYSIS
- Authors: Kharlamova U.V.1, Il'icheva O.E.1
-
Affiliations:
- Сhelyabinsk state medical academy of Federal agency on public health services and social development
- Issue: Vol 67, No 4 (2012)
- Pages: 25-29
- Section: CARDIOLOGY: CURRENT ISSUES
- Published: 23.04.2012
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/316
- DOI: https://doi.org/10.15690/vramn.v67i4.195
- ID: 316
Cite item
Full Text
Abstract
To study influence of markers of function endothelium on structurally functional indicators left ventricular at patients on a hemodialysis.. 98 patients on a hemodialysis are surveyed. To all patients defined concentration stable metabolites of oxyde nitrogen whey of blood, total cholesterol, cholesterol of low density lipoproteine, cholesterol of high density lipoproteine, triglycerides, homocysteine, Willebrand factor, spent echocardiography research. During correlation, multiple regression the analysis independent influence of indicators of function endothelium on structurally functional indicators of a myocardium left ventricular, processes of formation of dysfunction of heart reflecting parallelism and endothelium is revealed
Keywords
About the authors
U. V. Kharlamova
Сhelyabinsk state medical academy of Federal agency on public health services and social development
Author for correspondence.
Email: top120@yandex.ru
кандидат медицинских наук, ассистент кафедры внутренних болезней и военно- полевой терапии ГБОУ ВПО «Челябинская государственная медицинская академия» Минздравсоцразвития России Адрес: 454007, Челябинск, пр-т Ленина, д. 19, кв. 4 Тел.: 8(912) 472-38-20 Россия
O. E. Il'icheva
Сhelyabinsk state medical academy of Federal agency on public health services and social development
Email: pochka56@mail.ru
доктор медицинских наук, профессор кафедры внутренних болезней и военно- полевой терапии, декан лечебного факультета ГБОУ ВПО «Челябинская государственная медицинская академия» Минздравсоцразвития России Адрес: 454080, Челябинск, пр-т Ленина, д. 65, кв. 75 Россия
References
- Buval’cev V.I., Kamyshova T.V., Spasskaya M.B. i dr. Disfunkciya `endoteliya kak integral’nyj faktor riska ateroskleroza i vozmozhnosti ee korrekcii. Klinicheskaya farmakologiya i terapiya. 2002; 11(5): 30–32.
- Zagidullin N.Sh., Valeeva K.F., Gassanov N. i dr. Znachenie disfunkcii `endoteliya pri serdechno-sosudistyh zabolevaniyah i metody ee medikamentoznoj korrekcii . Kardiologiya. 2010; 5: 54–60.
- Bostom A., Brosnan J.T., Hall B. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis. 1995; 116: 59–62.
- Smirnov A.V., Esayan A.M., Kayukov I.G. i dr. Sovremennye podhody k zamedleniyu progressirovaniya hronicheskoj bolezni pochek. Nefrologiya. 2004; (3): 89–99.
- Hoenicb N.A. Platelet and leucocytes behaviour during haemodialysis. Contrib. Nephrol. 1999; 125: 120–132.
- Lang D., Kredan M.B., Lang D., Moat S.J. et al. Homocysteineinduced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions. Arterioscler. Thromb. Vasc. Biol. 2000; 5: 257–261.
- Dyadyk A.I., Kanella Dzh., Bagrij A.`E. i dr. Gipertrofiya levogo zheludochka serdca u bol’nyh s hronicheskoj pochechnoj nedostatochnost’yu. Ukr. kardiol. zhurn. 2000; 3: 81–87.
- Kremneva L.V., Shalaev S.V. Modificirovannye lipoproteiny nizkoj plotnosti: aterogennaya i provospalitel’naya aktivnost’, rol’ v patogeneze ostryh koronarnyh sindromov Ross. Kardiol. Zhurnal. 2004; 46 (2): 70–75.
- Manuhina E.B., Malyshev I.Yu. Rol’ oksida azota v serdechnososudistoj patologii: vzglyad patofiziologa. Ross. kard. Zhurn. 2000; 5: 55–63.
- Belenkov Yu.N. Remodelirovanie levogo zheludochka: kompleksnyj podhod. Serdechnaya nedostatochnost’. 2002; 4 (14): 161–163.
- Nasonov E.L., Baranov A.A., Shilkina N.P. Markery aktivacii `endoteliya (trombomodulin, antigen faktora Villebranda i angiotenzinprevraschayuschij ferment): klinicheskoe znachenie. Klinicheskaya medicina. 1998; 11: 4–9.
- Liu X., Luo F., Li J. et al. Homocysteine induces connective tissue grows factor expression in vascular smooth muscle cells. J Thromb. Haemost. 2008; 6 (1): 184–192.
- Zang C., Cai Y., Adachi M.T. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolder protein response. J. Biol. Chem. 2001; 276: 35867– 35874.
- Korandji C., Zeller M., Guilland J.C. et al. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. Clin. Biochem. 2007; 40 (1-2): 66–72.
- Ageev F.T., Ovchinnikov A.G. Diastolicheskaya disfunkciya kak proyavlenie remodelirovaniya serdca. Serdechnaya nedostatochnost’. 2002; 4 (14): 190–195.
Supplementary files
